GT Biopharma logo
GT Biopharma
GTBP | NASDAQ
Chart Builder DCF Calculator
$3.54
-$0.18 (-4.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
+$0.07 (+1.98%)
After-hours: Nov 16, 2026, 6:41 PM ET

GT Biopharma Balance Sheet

Balance sheet explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
6.81M 3.95M 1.08M 5.67M 8.97M 5.3M
– – 12.89M 10.84M 23.01M –
– – – – – –
– – – 9K – –
– – – – – –
– – – – – –
1.3M 281K – – – –
8.11M 4.23M 14.06M 16.56M 32.17M 5.66M
– – 53K 165K – –
– – – – – –
– – 53K 174K – –
8.11M 4.23M 14.11M 16.74M 32.17M 5.66M
748K 3.85M 4.33M 3.14M 8.19M 2.24M
– – – – 1.9M 6.13M
– – – – 31K 26.33M
11K 252K 1.05M 19K -1.76M -5.75M
2.32M 5.9M 6.63M 4.94M 10.26M 35.09M
– – – – – –
– – – – – –
– – – 64K – –
2.32M 5.9M 6.63M 5M 10.26M 35.09M
– – 58K 174K 31K 26.33M
5.79M -1.67M 7.48M 11.73M 21.91M -29.43M
26.24 -22.01 138.65 9.21 19.45 -167.81
26K 2K 1K 33K 1.15M 52K
-723.9M -695.23M -682.07M -674.47M -653.58M -595.63M
– – – – 1.11M –
5.79M -1.67M 7.48M 11.73M 21.91M -29.26M
– – 12.89M 10.84M 23.01M –

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.